Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

NCT00395421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: NM283 plus Peg-IFNα-2a

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]